Loading...
XKRX
027360
Market cap163mUSD
Dec 05, Last price  
2,085.00KRW
1D
2.21%
1Q
-1.88%
IPO
73.03%
Name

AJU IB INVESTMENT CO LTD

Chart & Performance

D1W1MN
XKRX:027360 chart
P/E
29.65
P/S
5.48
EPS
70.31
Div Yield, %
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
5.02%
Revenues
45.01b
-16.25%
22,618,598,68050,586,619,38074,202,757,65060,233,546,51565,471,966,05631,462,440,88318,565,485,07935,224,298,75934,440,026,62859,382,100,88523,798,297,25553,740,827,75045,009,326,000
Net income
8.32b
-49.89%
-5,805,914,0706,524,479,5509,626,506,18011,680,024,09715,087,852,43116,113,088,79614,562,286,37316,288,676,49549,437,362,10039,333,565,4302,039,024,79016,601,630,8188,318,603,000
CFO
24.07b
-3.23%
30,569,32025,496,704,73028,348,397,29065,178,233,85528,482,612,508-3,733,738,716-8,550,201,91125,933,976,566-3,078,743,09856,982,108,88522,168,831,93224,877,668,72924,074,935,000
Dividend
Dec 27, 202320 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Aju IB Investment Co., Ltd. is a venture capital and private equity arm of AJU Corporation Co., Ltd. It specializes in mezzanine, buyouts, corporate restructuring, and all stages of venture investments in small to medium sized start-up companies in South Korea. The firm considers investments in information technology including mobile service platforms, software, semiconductor, contents, biotechnology, life science, and environment sectors. For venture capital investments, it focuses on high technology sector and for private equity investments, the firm focuses on manufacturing sector. It typically invests in South Korea but also makes investments in other countries. The firm also considers investments in companies with main business in immune system platform technology, oncology drugs, and ophthalmic drugs. It also invests in information communication technology including Internet of Things, artificial intelligence, smart car, and advanced materials. The firm considers investments in companies that have been evaluated by technology credit bureaus or in companies with ratings of T5 and above, which is provided by technology credit bureaus. For the investments by the office in Boston, Massachusetts, the firm primarily invests in therapeutics serving large unmet medical need; enabling platform technologies with maturing lead candidate; potential for partnership or alliance with Korean pharmaceutical companies; other areas of interest are medical devices & diagnostics. It prefers to invest between $0.87 million to $2.61 million for venture capital investments and $4.36 million to $17.45 million for private equity investments. The firm typically exits through IPO and mergers and acquisitions. Aju IB Investment Co., Ltd., formerly known as Kibo Technology Advancing Capital Co., was founded in 1974 and is based in Seoul, South Korea with an additional office in Boston, Massachusetts.
IPO date
Nov 21, 2018
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT